Metraipolis › archive › dc_feb5949a9a2e
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer — Europe PMC PMID:42185502
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42185502
- DOI
- 10.1007/s00535-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T08:31:32.601Z
- SHA-256 of the archived text
0f25d5a4aa505fb7290068d9369b8fb7f790108db7baa78974fff3b29d9fb9b0- Stable URL of this page
https://metraipolis.com/documento/dc_feb5949a9a2e
How to cite
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer — Europe PMC PMID:42185502 — Europe PMC (en), https://europepmc.org/article/MED/42185502 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_feb5949a9a2e (Metraipolis archive dc_feb5949a9a2e, sha256 0f25d5a4aa505fb7290068d9369b8fb7f790108db7baa78974fff3b29d9fb9b0)
BibTeX
@misc{dcfeb5949a9a2e,
title = {Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer — Europe PMC PMID:42185502},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42185502},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_feb5949a9a2e; sha256 0f25d5a4aa505fb7290068d9369b8fb7f790108db7baa78974fff3b29d9fb9b0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42185502. Agents can read the archived copy with the MCP tool read_document.